Compare OPRT & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OPRT | LAB |
|---|---|---|
| Founded | 2005 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 275.7M | 326.2M |
| IPO Year | 2019 | 2008 |
| Metric | OPRT | LAB |
|---|---|---|
| Price | $8.13 | $0.68 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $7.00 | $1.35 |
| AVG Volume (30 Days) | 296.5K | ★ 1.6M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 127.18 | 61.54 |
| EPS | 0.22 | ★ 0.26 |
| Revenue | ★ $956,685,000.00 | $101,937,000.00 |
| Revenue This Year | $32.79 | N/A |
| Revenue Next Year | $4.47 | $2.63 |
| P/E Ratio | $35.77 | ★ $2.64 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.03 | $0.63 |
| 52 Week High | $8.30 | $1.72 |
| Indicator | OPRT | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 68.31 | 42.55 |
| Support Level | $4.89 | $0.63 |
| Resistance Level | $8.30 | $1.02 |
| Average True Range (ATR) | 0.30 | 0.04 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 96.30 | 53.06 |
Oportun Financial Corp is engaged in providing financial services to people who either do not have a credit score or who may have a limited credit history. The company offers Personal Loans, Auto Loans, unsecured personal loans, and secured personal loans, and provides deposit accounts, debit card services, and other transaction services to its customers. Its product offerings include small-dollar, unsecured installment loans and other products and services.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.